{
    "analytics_identifier":  null,
    "base_path":  "/guidance/human-t-cell-lymphotropic-virus-htlv-types-1-and-2",
    "content_id":  "8be5411e-350a-4a04-84ce-e8db4d69ed0c",
    "description":  "The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).",
    "details":  {
                    "attachments":  [

                                    ],
                    "body":  "\u003cdiv class=\"govspeak\"\u003e\u003ch2 id=\"overview\"\u003eOverview\u003c/h2\u003e\n\n\u003cp\u003eHuman T-cell lymphotropic virus types 1 and 2 (\u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e and \u003cabbr title=\"human T-cell lymphotropic virus type 2\"\u003eHTLV-2\u003c/abbr\u003e) are retroviruses found worldwide. Of the 2 viruses, \u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e has been more often associated with human disease. It is the causative agent of a form of blood cancer (adult T-cell leukaemia or lymphoma, called \u003cabbr title=\"adult T-cell leukaemia or lymphoma\"\u003eATL\u003c/abbr\u003e) and of a progressive disease of the nervous system (\u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e associated myelopathy, or \u003cabbr title=\"HTLV-1 associated myelopathy\"\u003eHAM\u003c/abbr\u003e, also known as tropical spastic paraparesis (\u003cabbr title=\"tropical spastic paraparesis\"\u003eTSP\u003c/abbr\u003e)).\u003c/p\u003e\n\n\u003ch2 id=\"epidemiology\"\u003eEpidemiology\u003c/h2\u003e\n\n\u003cp\u003e\u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e infects at least 5 million to 10 million people worldwide, although information is unavailable for many countries, so this figure is likely to be an underestimate. The virus is endemic in:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eCaribbean\u003c/li\u003e\n  \u003cli\u003eSouth America\u003c/li\u003e\n  \u003cli\u003eRomania\u003c/li\u003e\n  \u003cli\u003eIran\u003c/li\u003e\n  \u003cli\u003emuch of Africa\u003c/li\u003e\n  \u003cli\u003eJapan\u003c/li\u003e\n  \u003cli\u003eMelanesia\u003c/li\u003e\n  \u003cli\u003eindigenous population of Australia\u003c/li\u003e\n\u003c/ul\u003e\n\n\u003cp\u003eIn England and Wales, an estimated 22,000 people are living with the virus, mainly those who have migrated from endemic countries, or their descendants.\u003c/p\u003e\n\n\u003cp\u003e\u003ca href=\"https://www.gov.uk/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2019\" class=\"govuk-link\"\u003eSentinel surveillance of blood borne virus testing in England 2019 report\u003c/a\u003e includes \u003cabbr title=\"human T-cell lymphotropic virus\"\u003eHTLV\u003c/abbr\u003e testing data form participating sentinel centres across England.\u003c/p\u003e\n\n\u003ch2 id=\"virology\"\u003eVirology\u003c/h2\u003e\n\n\u003cp\u003e\u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e is an enveloped, single-stranded \u003cabbr title=\"Ribonucleic acid\"\u003eRNA\u003c/abbr\u003e virus of the family Retroviridae. The virus displays CD4 T-cell tropism and spread is by direct cell-to-cell contact. Viral \u003cabbr title=\"Ribonucleic acid\"\u003eRNA\u003c/abbr\u003e is not found in plasma. New infection is therefore usually the result of the transfer of infected lymphocytes rather than cell-free particles. After entering a cell, \u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e \u003cabbr title=\"Ribonucleic acid\"\u003eRNA\u003c/abbr\u003e is reverse transcribed into \u003cabbr title=\"Deoxyribonucleic acid\"\u003eDNA\u003c/abbr\u003e, which integrates into the host genome, where it is termed a provirus.\u003c/p\u003e\n\n\u003cp\u003e\u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e is oncogenic (cancer-causing) and this is mediated through interaction between viral and host proteins, leading to T-cell proliferation and transformation. \u003cabbr title=\"HTLV-1 associated myelopathy\"\u003eHAM\u003c/abbr\u003e/\u003cabbr title=\"tropical spastic paraparesis\"\u003eTSP\u003c/abbr\u003e is driven by the cellular immune response mounted against \u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e, which causes damage to the central nervous system.\u003c/p\u003e\n\n\u003ch2 id=\"transmission\"\u003eTransmission\u003c/h2\u003e\n\n\u003cp\u003e\u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e is transmitted through many routes:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003emother to child, especially through breastfeeding; also during pregnancy and giving birth\u003c/li\u003e\n  \u003cli\u003esex\u003c/li\u003e\n  \u003cli\u003einjection drug use\u003c/li\u003e\n  \u003cli\u003eblood transfusions and organ transplantation\u003c/li\u003e\n  \u003cli\u003eoccupational exposure\u003c/li\u003e\n  \u003cli\u003ecertain cultural and religious practices (such as flagellation)\u003c/li\u003e\n\u003c/ul\u003e\n\n\u003cp\u003eDue to the risk of transmission through blood transfusion, new blood donors and returning donors of unknown status are tested for \u003cabbr title=\"human T-cell lymphotropic virus\"\u003eHTLV\u003c/abbr\u003e in the UK; organ donors are also tested.\u003c/p\u003e\n\n\u003ch2 id=\"clinical-features\"\u003eClinical features\u003c/h2\u003e\n\n\u003cp\u003eAbout 5% to 10% of people with \u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e will develop a recognised associated clinical condition. In addition, mortality is higher in people with \u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e who do not have a recognised condition, but the reason for this is as yet unknown.\u003c/p\u003e\n\n\u003ch3 id=\"adult-t-cell-leukaemia-or-lymphoma-atl\"\u003eAdult T-cell leukaemia or lymphoma (\u003cabbr title=\"adult T-cell leukaemia or lymphoma\"\u003eATL\u003c/abbr\u003e)\u003c/h3\u003e\n\n\u003cp\u003eClinical features of \u003cabbr title=\"adult T-cell leukaemia or lymphoma\"\u003eATL\u003c/abbr\u003e include:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003egeneralised swelling of the lymph nodes\u003c/li\u003e\n  \u003cli\u003eenlarged liver and spleen\u003c/li\u003e\n  \u003cli\u003eimmunosuppression\u003c/li\u003e\n  \u003cli\u003ehigh blood calcium levels\u003c/li\u003e\n  \u003cli\u003ebone and skin lesions\u003c/li\u003e\n\u003c/ul\u003e\n\n\u003cp\u003eOf the 4 types of \u003cabbr title=\"adult T-cell leukaemia or lymphoma\"\u003eATL\u003c/abbr\u003e, the acute and lymphoma forms are the most aggressive, with a median survival of less than one year.\u003c/p\u003e\n\n\u003ch3 id=\"htlv-1-associated-myelopathy-ham-or-tropical-spastic-paraparesis-tsp\"\u003e\n\u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e associated myelopathy (\u003cabbr title=\"HTLV-1 associated myelopathy\"\u003eHAM\u003c/abbr\u003e) or tropical spastic paraparesis (\u003cabbr title=\"tropical spastic paraparesis\"\u003eTSP\u003c/abbr\u003e)\u003c/h3\u003e\n\n\u003cp\u003e\u003cabbr title=\"HTLV-1 associated myelopathy\"\u003eHAM\u003c/abbr\u003e, also known as \u003cabbr title=\"tropical spastic paraparesis\"\u003eTSP\u003c/abbr\u003e, is characterised by progressive weakness and spasticity of both legs. The prognosis is variable but a substantial proportion of individuals will not be able to walk unaided 10 years after onset, with 50% eventually becoming wheelchair dependent.\u003c/p\u003e\n\n\u003ch3 id=\"other-clinical-conditions\"\u003eOther clinical conditions\u003c/h3\u003e\n\n\u003cp\u003eOther clinical conditions associated with \u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e infection include:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003euveitis (inflammation of the middle part of the eye)\u003c/li\u003e\n  \u003cli\u003einfective dermatitis (eczema-like skin rash)\u003c/li\u003e\n  \u003cli\u003edisseminated strongyloidiasis (a parasitic helminth worm)\u003c/li\u003e\n  \u003cli\u003edamage to the peripheral nerves\u003c/li\u003e\n  \u003cli\u003ebronchiectasis (inflammation and widening of the airways with build-up of mucous)\u003c/li\u003e\n  \u003cli\u003einflammation of the joints\u003c/li\u003e\n\u003c/ul\u003e\n\n\u003ch2 id=\"diagnosis\"\u003eDiagnosis\u003c/h2\u003e\n\n\u003cp\u003eThe diagnosis of \u003cabbr title=\"human T-cell lymphotropic virus\"\u003eHTLV\u003c/abbr\u003e infection is usually made by testing for \u003cabbr title=\"human T-cell lymphotropic virus\"\u003eHTLV\u003c/abbr\u003e antibodies in blood samples using enzyme-linked immunoassay. Reactive samples are confirmed by a Western blot or line assay, which also type the infection. Where serology is inconclusive, \u003cabbr title=\"polymerase chain reaction\"\u003ePCR\u003c/abbr\u003e for proviral \u003cabbr title=\"Deoxyribonucleic acid\"\u003eDNA\u003c/abbr\u003e is performed. For this, whole blood is required to allow extraction of \u003cabbr title=\"Deoxyribonucleic acid\"\u003eDNA\u003c/abbr\u003e from lymphocytes.\u003c/p\u003e\n\n\u003ch2 id=\"treatment-and-prevention\"\u003eTreatment and prevention\u003c/h2\u003e\n\n\u003cp\u003eTreatment is not indicated for people living with \u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e who do not have a clinical condition.\u003c/p\u003e\n\n\u003cp\u003eHowever, all individuals are recommended to attend specialist services regularly to:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003epromptly identify the onset of any symptoms\u003c/li\u003e\n  \u003cli\u003eaccess clinical trials in those cases where therapy is required\u003c/li\u003e\n  \u003cli\u003eseek advice on how to prevent transmission to others, such as through the avoidance of breastfeeding, not donating blood and use of condoms when having sex\u003c/li\u003e\n\u003c/ul\u003e\n\n\u003cp\u003eScreening for associated diseases, such as strongyloidiasis, is offered to people who are newly diagnosed.\u003c/p\u003e\n\n\u003cp\u003eAlthough anti-\u003cabbr title=\"human immunodeficiency virus\"\u003eHIV\u003c/abbr\u003e drugs, which have activity against the \u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e reverse transcriptase (\u003cabbr title=\"reverse transcriptase\"\u003eRT\u003c/abbr\u003e) and integrase enzymes have been tested in limited clinical trials, \u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e proviral \u003cabbr title=\"Deoxyribonucleic acid\"\u003eDNA\u003c/abbr\u003e level is not reduced. Anti-\u003cabbr title=\"human immunodeficiency virus\"\u003eHIV\u003c/abbr\u003e protease inhibitors and non-nucleoside reverse transcriptase inhibitors (\u003cabbr title=\"non-nucleoside reverse transcriptase inhibitors\"\u003eNNRTI\u003c/abbr\u003e) have no anti-\u003cabbr title=\"human T-cell lymphotropic virus\"\u003eHTLV\u003c/abbr\u003e activity. \u003cabbr title=\"reverse transcriptase\"\u003eRT\u003c/abbr\u003e and integrase inhibitors may have a role in prevention of \u003cabbr title=\"human T-cell lymphotropic virus\"\u003eHTLV\u003c/abbr\u003e infection but further studies are required to confirm this (see \u003ca href=\"#PEP\" class=\"govuk-link\"\u003e\u003cabbr title=\"post exposure prophylaxis\"\u003ePEP\u003c/abbr\u003e section\u003c/a\u003e).\u003c/p\u003e\n\n\u003cp\u003e\u003cabbr title=\"adult T-cell leukaemia or lymphoma\"\u003eATL\u003c/abbr\u003e can be treated with chemotherapy, monoclonal antibodies or bone marrow transplant, but treatment outcomes are often poor. Zidovudine and interferon-alpha is the recommended first-line treatment for leukaemic forms of \u003cabbr title=\"adult T-cell leukaemia or lymphoma\"\u003eATL\u003c/abbr\u003e. Prophylaxis against opportunistic infections is important. Corticosteroids and steroid-sparing anti-inflammatory agents may slow progression in some patients with \u003cabbr title=\"HTLV-1 associated myelopathy\"\u003eHAM\u003c/abbr\u003e/\u003cabbr title=\"tropical spastic paraparesis\"\u003eTSP\u003c/abbr\u003e; a monoclonal antibody is also being tested in clinical trials. International recommendations have recently been published for \u003cabbr title=\"adult T-cell leukaemia or lymphoma\"\u003eATL\u003c/abbr\u003e and \u003cabbr title=\"HTLV-1 associated myelopathy\"\u003eHAM\u003c/abbr\u003e/\u003cabbr title=\"tropical spastic paraparesis\"\u003eTSP\u003c/abbr\u003e management.\u003c/p\u003e\n\n\u003cp\u003eBetter treatments are urgently needed for conditions caused by \u003cabbr title=\"human T-cell lymphotropic virus\"\u003eHTLV\u003c/abbr\u003e and general recommendations beyond the management of \u003cabbr title=\"HTLV-1 associated myelopathy\"\u003eHAM\u003c/abbr\u003e/\u003cabbr title=\"tropical spastic paraparesis\"\u003eTSP\u003c/abbr\u003e and \u003cabbr title=\"adult T-cell leukaemia or lymphoma\"\u003eATL\u003c/abbr\u003e cannot yet be made.\u003c/p\u003e\n\n\u003ch3 id=\"PEP\"\u003ePost exposure prophylaxis (\u003cabbr title=\"post exposure prophylaxis\"\u003ePEP\u003c/abbr\u003e)\u003c/h3\u003e\n\u003cp\u003eFew cases of occupational exposure have been described in the literature and no instances where prophylaxis has been given after an \u003cabbr title=\"human T-cell lymphotropic virus\"\u003eHTLV\u003c/abbr\u003e exposure in humans. Significant exposures include exposure to cellular fluid (such as whole blood) of an \u003cabbr title=\"human T-cell lymphotropic virus\"\u003eHTLV\u003c/abbr\u003e-infected patient through needlestick injury, particularly where the proviral \u003cabbr title=\"Deoxyribonucleic acid\"\u003eDNA\u003c/abbr\u003e level is high.\u003c/p\u003e\n\n\u003cp\u003eIn vitro data show that raltegravir, a drug that prevents integration of \u003cabbr title=\"human immunodeficiency virus\"\u003eHIV\u003c/abbr\u003e \u003cabbr title=\"Deoxyribonucleic acid\"\u003eDNA\u003c/abbr\u003e into the host genome, and certain \u003cabbr title=\"human immunodeficiency virus\"\u003eHIV\u003c/abbr\u003e-1 nucleoside analogue reverse transcriptase inhibitors also have activity against \u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e. In the absence of clinical data, some specialists recommend that individuals who have sustained a significant occupational exposure to \u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e should receive post exposure prophylaxis with raltegravir, zidovudine and lamivudine for 6 weeks.\u003c/p\u003e\n\n\u003ch2 id=\"htlv-2\"\u003e\u003cabbr title=\"human T-cell lymphotropic virus type 2\"\u003eHTLV-2\u003c/abbr\u003e\u003c/h2\u003e\n\n\u003cp\u003e\u003cabbr title=\"human T-cell lymphotropic virus type 2\"\u003eHTLV-2\u003c/abbr\u003e has mainly been detected in indigenous Americans and people from Western Africa; it is less common in the UK than \u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e. Transmission is through the same routes as \u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e, with a particularly strong association with injecting drug use in some groups. However, there are no recent data on the prevalence of \u003cabbr title=\"human T-cell lymphotropic virus type 2\"\u003eHTLV-2\u003c/abbr\u003e in people who inject drugs in the UK. \u003cabbr title=\"human T-cell lymphotropic virus type 2\"\u003eHTLV-2\u003c/abbr\u003e is less frequently associated with disease than \u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e and, where disease does occur, it is generally milder. However, there is currently little information available about the role of \u003cabbr title=\"human T-cell lymphotropic virus type 2\"\u003eHTLV-2\u003c/abbr\u003e in disease.\u003c/p\u003e\n\n\u003ch2 id=\"surveillance\"\u003eSurveillance\u003c/h2\u003e\n\n\u003cp\u003e\u003cabbr title=\"Public Health England\"\u003ePHE\u003c/abbr\u003e coordinates national \u003cabbr title=\"human T-cell lymphotropic virus\"\u003eHTLV\u003c/abbr\u003e surveillance activities. Laboratory reports of new diagnoses are received from the \u003cabbr title=\"Public Health England\"\u003ePHE\u003c/abbr\u003e Viral Reference Department (\u003cabbr title=\"Viral Reference Department\"\u003eVRD\u003c/abbr\u003e), at Colindale, which confirms all \u003cabbr title=\"human T-cell lymphotropic virus\"\u003eHTLV\u003c/abbr\u003e diagnoses in England and Wales. Clinical data on new diagnoses are received on an annual basis from the 4 centres providing specialist \u003cabbr title=\"human T-cell lymphotropic virus type 1\"\u003eHTLV-1\u003c/abbr\u003e care below:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eSt Mary’s Hospital (Imperial College Healthcare \u003cabbr title=\"National Health Service\"\u003eNHS\u003c/abbr\u003e Trust)\u003c/li\u003e\n  \u003cli\u003eQueen Elizabeth Hospital Birmingham (University Hospitals Birmingham \u003cabbr title=\"National Health Service\"\u003eNHS\u003c/abbr\u003e Trust)\u003c/li\u003e\n  \u003cli\u003eNorth Manchester General Hospital (Pennine Acute Hospitals \u003cabbr title=\"National Health Service\"\u003eNHS\u003c/abbr\u003e Trust)\u003c/li\u003e\n  \u003cli\u003eMonkgate Health Centre (York Teaching Hospital \u003cabbr title=\"National Health Service\"\u003eNHS\u003c/abbr\u003e Foundation Trust)\u003c/li\u003e\n\u003c/ul\u003e\n\n\u003cp\u003e\u003cabbr title=\"human T-cell lymphotropic virus\"\u003eHTLV\u003c/abbr\u003e diagnoses data from the \u003cabbr title=\"National Health Service Blood and Transplant\"\u003eNHSBT\u003c/abbr\u003e, which monitors \u003cabbr title=\"human T-cell lymphotropic virus\"\u003eHTLV\u003c/abbr\u003e infection in blood donors, are also incorporated into the surveillance dataset.\u003c/p\u003e\n\n\u003c/div\u003e",
                    "change_history":  [
                                           {
                                               "note":  "Added link to the Sentinel surveillance of blood borne virus testing in England 2019 report.",
                                               "public_timestamp":  "2021-03-23T09:32:23.000+00:00"
                                           },
                                           {
                                               "note":  "First published.",
                                               "public_timestamp":  "2020-09-07T09:30:00.000+01:00"
                                           }
                                       ],
                    "emphasised_organisations":  [
                                                     "80091cd8-7a8f-41ef-8faf-8af91fce4fdb"
                                                 ],
                    "first_public_at":  "2020-09-07T09:30:00.000+01:00",
                    "political":  false,
                    "related_mainstream_content":  [

                                                   ],
                    "tags":  {
                                 "browse_pages":  [

                                                  ],
                                 "topics":  [
                                                "9b754788-611c-46b1-a65f-2f10fec5e273"
                                            ]
                             }
                },
    "document_type":  "detailed_guide",
    "first_published_at":  "2020-09-07T09:30:00+01:00",
    "links":  {
                  "available_translations":  [
                                                 {
                                                     "api_path":  "/api/content/guidance/human-t-cell-lymphotropic-virus-htlv-types-1-and-2",
                                                     "api_url":  "https://www.gov.uk/api/content/guidance/human-t-cell-lymphotropic-virus-htlv-types-1-and-2",
                                                     "base_path":  "/guidance/human-t-cell-lymphotropic-virus-htlv-types-1-and-2",
                                                     "content_id":  "8be5411e-350a-4a04-84ce-e8db4d69ed0c",
                                                     "document_type":  "detailed_guide",
                                                     "links":  {

                                                               },
                                                     "locale":  "en",
                                                     "public_updated_at":  "2021-03-23T09:32:23Z",
                                                     "schema_name":  "detailed_guide",
                                                     "title":  "Human T-cell lymphotropic virus (HTLV) types 1 and 2",
                                                     "web_url":  "https://www.gov.uk/guidance/human-t-cell-lymphotropic-virus-htlv-types-1-and-2",
                                                     "withdrawn":  false
                                                 }
                                             ],
                  "government":  [
                                     {
                                         "api_path":  "/api/content/government/2015-conservative-government",
                                         "api_url":  "https://www.gov.uk/api/content/government/2015-conservative-government",
                                         "base_path":  "/government/2015-conservative-government",
                                         "content_id":  "d4fbc1b9-d47d-4386-af04-ac909f868f92",
                                         "details":  {
                                                         "current":  false,
                                                         "ended_on":  "2016-07-13T00:00:00+00:00",
                                                         "started_on":  "2015-05-08T00:00:00+00:00"
                                                     },
                                         "document_type":  "government",
                                         "links":  {

                                                   },
                                         "locale":  "en",
                                         "title":  "2015 to 2016 Cameron Conservative government",
                                         "web_url":  "https://www.gov.uk/government/2015-conservative-government"
                                     }
                                 ],
                  "organisations":  [
                                        {
                                            "analytics_identifier":  "EA1328",
                                            "api_path":  "/api/content/government/organisations/uk-health-security-agency",
                                            "api_url":  "https://www.gov.uk/api/content/government/organisations/uk-health-security-agency",
                                            "base_path":  "/government/organisations/uk-health-security-agency",
                                            "content_id":  "80091cd8-7a8f-41ef-8faf-8af91fce4fdb",
                                            "details":  {
                                                            "acronym":  "UKHSA",
                                                            "brand":  "department-of-health",
                                                            "default_news_image":  {
                                                                                       "high_resolution_url":  "https://assets.publishing.service.gov.uk/media/674de56feb52380f5456af9f/s960_News_logo.png",
                                                                                       "url":  "https://assets.publishing.service.gov.uk/media/674de56f20e5fc28f0a59fbb/s300_News_logo.png"
                                                                                   },
                                                            "logo":  {
                                                                         "crest":  "single-identity",
                                                                         "formatted_title":  "UK Health\u003cbr/\u003eSecurity\u003cbr/\u003eAgency"
                                                                     },
                                                            "organisation_govuk_status":  {
                                                                                              "status":  "live",
                                                                                              "updated_at":  null,
                                                                                              "url":  null
                                                                                          }
                                                        },
                                            "document_type":  "organisation",
                                            "links":  {

                                                      },
                                            "locale":  "en",
                                            "schema_name":  "organisation",
                                            "title":  "UK Health Security Agency",
                                            "web_url":  "https://www.gov.uk/government/organisations/uk-health-security-agency",
                                            "withdrawn":  false
                                        }
                                    ],
                  "original_primary_publishing_organisation":  [
                                                                   {
                                                                       "analytics_identifier":  "EA480",
                                                                       "api_path":  "/api/content/government/organisations/public-health-england",
                                                                       "api_url":  "https://www.gov.uk/api/content/government/organisations/public-health-england",
                                                                       "base_path":  "/government/organisations/public-health-england",
                                                                       "content_id":  "1343f283-19e9-4fbb-86b1-58c7549d874b",
                                                                       "details":  {
                                                                                       "acronym":  "PHE",
                                                                                       "brand":  "department-of-health",
                                                                                       "default_news_image":  {
                                                                                                                  "high_resolution_url":  "https://assets.publishing.service.gov.uk/media/5a37db2de5274a7908e352ef/s960_sign5.jpg",
                                                                                                                  "url":  "https://assets.publishing.service.gov.uk/media/5a37db2d40f0b649cceb18bf/s300_sign5.jpg"
                                                                                                              },
                                                                                       "logo":  {
                                                                                                    "crest":  "single-identity",
                                                                                                    "formatted_title":  "Public Health \u003cbr/\u003eEngland"
                                                                                                },
                                                                                       "organisation_govuk_status":  {
                                                                                                                         "status":  "split",
                                                                                                                         "updated_at":  "2021-10-01T00:00:00.000+01:00",
                                                                                                                         "url":  "https://www.gov.uk/phe"
                                                                                                                     }
                                                                                   },
                                                                       "document_type":  "organisation",
                                                                       "links":  {

                                                                                 },
                                                                       "locale":  "en",
                                                                       "schema_name":  "organisation",
                                                                       "title":  "Public Health England",
                                                                       "web_url":  "https://www.gov.uk/government/organisations/public-health-england",
                                                                       "withdrawn":  false
                                                                   }
                                                               ],
                  "primary_publishing_organisation":  [
                                                          {
                                                              "analytics_identifier":  "EA1328",
                                                              "api_path":  "/api/content/government/organisations/uk-health-security-agency",
                                                              "api_url":  "https://www.gov.uk/api/content/government/organisations/uk-health-security-agency",
                                                              "base_path":  "/government/organisations/uk-health-security-agency",
                                                              "content_id":  "80091cd8-7a8f-41ef-8faf-8af91fce4fdb",
                                                              "details":  {
                                                                              "acronym":  "UKHSA",
                                                                              "brand":  "department-of-health",
                                                                              "default_news_image":  {
                                                                                                         "high_resolution_url":  "https://assets.publishing.service.gov.uk/media/674de56feb52380f5456af9f/s960_News_logo.png",
                                                                                                         "url":  "https://assets.publishing.service.gov.uk/media/674de56f20e5fc28f0a59fbb/s300_News_logo.png"
                                                                                                     },
                                                                              "logo":  {
                                                                                           "crest":  "single-identity",
                                                                                           "formatted_title":  "UK Health\u003cbr/\u003eSecurity\u003cbr/\u003eAgency"
                                                                                       },
                                                                              "organisation_govuk_status":  {
                                                                                                                "status":  "live",
                                                                                                                "updated_at":  null,
                                                                                                                "url":  null
                                                                                                            }
                                                                          },
                                                              "document_type":  "organisation",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "schema_name":  "organisation",
                                                              "title":  "UK Health Security Agency",
                                                              "web_url":  "https://www.gov.uk/government/organisations/uk-health-security-agency",
                                                              "withdrawn":  false
                                                          }
                                                      ],
                  "suggested_ordered_related_items":  [
                                                          {
                                                              "api_path":  "/api/content/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2019",
                                                              "api_url":  "https://www.gov.uk/api/content/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2019",
                                                              "base_path":  "/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2019",
                                                              "content_id":  "b507893e-3f17-4d68-b08c-5b66e3c9a846",
                                                              "document_type":  "research",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "public_updated_at":  "2021-01-19T15:40:00Z",
                                                              "schema_name":  "publication",
                                                              "title":  "Sentinel surveillance of blood borne virus testing in England 2019",
                                                              "web_url":  "https://www.gov.uk/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2019",
                                                              "withdrawn":  false
                                                          },
                                                          {
                                                              "api_path":  "/api/content/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2017",
                                                              "api_url":  "https://www.gov.uk/api/content/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2017",
                                                              "base_path":  "/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2017",
                                                              "content_id":  "175179f7-a8f9-4310-909a-6cc743245e1d",
                                                              "document_type":  "research",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "public_updated_at":  "2018-10-05T15:56:43Z",
                                                              "schema_name":  "publication",
                                                              "title":  "Sentinel surveillance of blood borne virus testing in England: 2017",
                                                              "web_url":  "https://www.gov.uk/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2017",
                                                              "withdrawn":  false
                                                          },
                                                          {
                                                              "api_path":  "/api/content/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2016",
                                                              "api_url":  "https://www.gov.uk/api/content/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2016",
                                                              "base_path":  "/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2016",
                                                              "content_id":  "0481cc4d-d958-49e3-8276-d7a3abfd43d5",
                                                              "document_type":  "research",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "public_updated_at":  "2017-07-28T15:15:15Z",
                                                              "schema_name":  "publication",
                                                              "title":  "Sentinel surveillance of blood borne virus testing in England: 2016",
                                                              "web_url":  "https://www.gov.uk/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2016",
                                                              "withdrawn":  false
                                                          },
                                                          {
                                                              "api_path":  "/api/content/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2018",
                                                              "api_url":  "https://www.gov.uk/api/content/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2018",
                                                              "base_path":  "/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2018",
                                                              "content_id":  "3affd74f-9f8a-4b70-99cc-a2c39d044600",
                                                              "document_type":  "research",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "public_updated_at":  "2020-01-14T13:00:02Z",
                                                              "schema_name":  "publication",
                                                              "title":  "Sentinel surveillance of blood borne virus testing in England: 2018",
                                                              "web_url":  "https://www.gov.uk/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2018",
                                                              "withdrawn":  false
                                                          },
                                                          {
                                                              "api_path":  "/api/content/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2015",
                                                              "api_url":  "https://www.gov.uk/api/content/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2015",
                                                              "base_path":  "/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2015",
                                                              "content_id":  "363a4aac-e235-43ee-bc9c-5a30a51a38c3",
                                                              "document_type":  "research",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "public_updated_at":  "2016-07-22T20:50:13Z",
                                                              "schema_name":  "publication",
                                                              "title":  "Sentinel surveillance of blood borne virus testing in England: 2015",
                                                              "web_url":  "https://www.gov.uk/government/publications/sentinel-surveillance-of-blood-borne-virus-testing-in-england-2015",
                                                              "withdrawn":  false
                                                          }
                                                      ],
                  "taxons":  [
                                 {
                                     "api_path":  "/api/content/health-and-social-care/health-protection-infectious-diseases",
                                     "api_url":  "https://www.gov.uk/api/content/health-and-social-care/health-protection-infectious-diseases",
                                     "base_path":  "/health-and-social-care/health-protection-infectious-diseases",
                                     "content_id":  "c31256e8-f328-462b-993f-dce50b7892e9",
                                     "details":  {
                                                     "internal_name":  "Infectious diseases [T]",
                                                     "notes_for_editors":  "",
                                                     "visible_to_departmental_editors":  false
                                                 },
                                     "document_type":  "taxon",
                                     "links":  {
                                                   "parent_taxons":  [
                                                                         {
                                                                             "api_path":  "/api/content/health-and-social-care/health-protection",
                                                                             "api_url":  "https://www.gov.uk/api/content/health-and-social-care/health-protection",
                                                                             "base_path":  "/health-and-social-care/health-protection",
                                                                             "content_id":  "30ba2d05-d0d6-4978-a5d6-707511894111",
                                                                             "description":  "",
                                                                             "details":  {
                                                                                             "internal_name":  "Health protection",
                                                                                             "notes_for_editors":  "",
                                                                                             "visible_to_departmental_editors":  false
                                                                                         },
                                                                             "document_type":  "taxon",
                                                                             "links":  {
                                                                                           "parent_taxons":  [
                                                                                                                 {
                                                                                                                     "api_path":  "/api/content/health-and-social-care/public-health",
                                                                                                                     "api_url":  "https://www.gov.uk/api/content/health-and-social-care/public-health",
                                                                                                                     "base_path":  "/health-and-social-care/public-health",
                                                                                                                     "content_id":  "d6a4884e-769d-4b81-8ba5-b64394362d92",
                                                                                                                     "description":  "",
                                                                                                                     "details":  {
                                                                                                                                     "internal_name":  "Public health",
                                                                                                                                     "notes_for_editors":  "",
                                                                                                                                     "visible_to_departmental_editors":  false
                                                                                                                                 },
                                                                                                                     "document_type":  "taxon",
                                                                                                                     "links":  {
                                                                                                                                   "parent_taxons":  ""
                                                                                                                               },
                                                                                                                     "locale":  "en",
                                                                                                                     "phase":  "live",
                                                                                                                     "public_updated_at":  "2018-09-17T15:15:14Z",
                                                                                                                     "schema_name":  "taxon",
                                                                                                                     "title":  "Public health",
                                                                                                                     "web_url":  "https://www.gov.uk/health-and-social-care/public-health",
                                                                                                                     "withdrawn":  false
                                                                                                                 }
                                                                                                             ]
                                                                                       },
                                                                             "locale":  "en",
                                                                             "phase":  "live",
                                                                             "public_updated_at":  "2019-03-11T14:19:39Z",
                                                                             "schema_name":  "taxon",
                                                                             "title":  "Health protection",
                                                                             "web_url":  "https://www.gov.uk/health-and-social-care/health-protection",
                                                                             "withdrawn":  false
                                                                         }
                                                                     ]
                                               },
                                     "locale":  "en",
                                     "phase":  "live",
                                     "public_updated_at":  "2018-08-22T12:56:17Z",
                                     "schema_name":  "taxon",
                                     "title":  "Infectious diseases",
                                     "web_url":  "https://www.gov.uk/health-and-social-care/health-protection-infectious-diseases",
                                     "withdrawn":  false
                                 }
                             ]
              },
    "locale":  "en",
    "phase":  "live",
    "public_updated_at":  "2021-03-23T09:32:23+00:00",
    "publishing_app":  "whitehall",
    "publishing_request_id":  "21-1684312368.980-10.13.22.30-13090",
    "publishing_scheduled_at":  "2020-09-07T09:30:00+01:00",
    "rendering_app":  "government-frontend",
    "scheduled_publishing_delay_seconds":  2,
    "schema_name":  "detailed_guide",
    "title":  "Human T-cell lymphotropic virus (HTLV) types 1 and 2",
    "updated_at":  "2024-12-18T09:41:31+00:00",
    "withdrawn_notice":  {

                         }
}
